APO RESEARCH · REPORT
Hemostat Powder
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Product & engineering
Understand the product.
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
Selected research
Industry Research
Hemostat Powder Industry Research Report 2026
Market perspective
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.
Report Scope
This report quantifies the global Hemostat Powder market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemostat Powder Market by Company
Johnson & Johnson
C. R. Bard
Pfizer
CSL Behring
Gelita Medical
Ferrosan Medical Devices
Baxter
Celox
Equimedical
Medira
Biocer
Hemostasis
MBP
Hemostat Powder Segment by Type
Gelatin
Fibrin
Cellulose
Others
Hemostat Powder Segment by Application
Surgical Wound Care
General Wound Care
Hemostat Powder Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostat Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemostat Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostat Powder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemostat Powder manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemostat Powder by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemostat Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gelatin
- Fibrin
- Cellulose
- Others
Applications
- Surgical Wound Care
- General Wound Care
Companies covered
- Johnson & Johnson
- C. R. Bard
- Pfizer
- CSL Behring
- Gelita Medical
- Ferrosan Medical Devices
- Baxter
- Celox
- Equimedical
- Medira
- Biocer
- Hemostasis
- MBP
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemostat Powder Market Size (2021-2032)
- 2.2.2 Global Hemostat Powder Sales (2021-2032)
- 2.2.3 Global Hemostat Powder Market Average Price (2021-2032)
- 2.3 Hemostat Powder by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gelatin
- 2.3.3 Fibrin
- 2.3.4 Cellulose
- 2.3.5 Others
- 2.4 Hemostat Powder by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgical Wound Care
- 2.4.3 General Wound Care
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemostat Powder Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemostat Powder Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hemostat Powder Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemostat Powder Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemostat Powder Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemostat Powder, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemostat Powder, Product Type & Application
- 3.8 Global Manufacturers of Hemostat Powder, Established Date
- 3.9 Global Hemostat Powder Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Hemostat Powder Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 C. R. Bard
- 4.2.1 C. R. Bard Company Information
- 4.2.2 C. R. Bard Business Overview
- 4.2.3 C. R. Bard Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 C. R. Bard Hemostat Powder Product Portfolio
- 4.2.5 C. R. Bard Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Hemostat Powder Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 CSL Behring
- 4.4.1 CSL Behring Company Information
- 4.4.2 CSL Behring Business Overview
- 4.4.3 CSL Behring Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CSL Behring Hemostat Powder Product Portfolio
- 4.4.5 CSL Behring Recent Developments
- 4.5 Gelita Medical
- 4.5.1 Gelita Medical Company Information
- 4.5.2 Gelita Medical Business Overview
- 4.5.3 Gelita Medical Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Gelita Medical Hemostat Powder Product Portfolio
- 4.5.5 Gelita Medical Recent Developments
- 4.6 Ferrosan Medical Devices
- 4.6.1 Ferrosan Medical Devices Company Information
- 4.6.2 Ferrosan Medical Devices Business Overview
- 4.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ferrosan Medical Devices Hemostat Powder Product Portfolio
- 4.6.5 Ferrosan Medical Devices Recent Developments
- 4.7 Baxter
- 4.7.1 Baxter Company Information
- 4.7.2 Baxter Business Overview
- 4.7.3 Baxter Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Baxter Hemostat Powder Product Portfolio
- 4.7.5 Baxter Recent Developments
- 4.8 Celox
- 4.8.1 Celox Company Information
- 4.8.2 Celox Business Overview
- 4.8.3 Celox Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Celox Hemostat Powder Product Portfolio
- 4.8.5 Celox Recent Developments
- 4.9 Equimedical
- 4.9.1 Equimedical Company Information
- 4.9.2 Equimedical Business Overview
- 4.9.3 Equimedical Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Equimedical Hemostat Powder Product Portfolio
- 4.9.5 Equimedical Recent Developments
- 4.10 Medira
- 4.10.1 Medira Company Information
- 4.10.2 Medira Business Overview
- 4.10.3 Medira Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Medira Hemostat Powder Product Portfolio
- 4.10.5 Medira Recent Developments
- 4.11 Biocer
- 4.11.1 Biocer Company Information
- 4.11.2 Biocer Business Overview
- 4.11.3 Biocer Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Biocer Hemostat Powder Product Portfolio
- 4.11.5 Biocer Recent Developments
- 4.12 Hemostasis
- 4.12.1 Hemostasis Company Information
- 4.12.2 Hemostasis Business Overview
- 4.12.3 Hemostasis Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hemostasis Hemostat Powder Product Portfolio
- 4.12.5 Hemostasis Recent Developments
- 4.13 MBP
- 4.13.1 MBP Company Information
- 4.13.2 MBP Business Overview
- 4.13.3 MBP Hemostat Powder Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 MBP Hemostat Powder Product Portfolio
- 4.13.5 MBP Recent Developments
5 Global Hemostat Powder Market Scenario by Region
- 5.1 Global Hemostat Powder Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemostat Powder Sales by Region: 2021-2032
- 5.2.1 Global Hemostat Powder Sales by Region: 2021-2026
- 5.2.2 Global Hemostat Powder Sales by Region: 2027-2032
- 5.3 Global Hemostat Powder Revenue by Region: 2021-2032
- 5.3.1 Global Hemostat Powder Revenue by Region: 2021-2026
- 5.3.2 Global Hemostat Powder Revenue by Region: 2027-2032
- 5.4 North America Hemostat Powder Market Facts & Figures by Country
- 5.4.1 North America Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemostat Powder Sales by Country (2021-2032)
- 5.4.3 North America Hemostat Powder Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemostat Powder Market Facts & Figures by Country
- 5.5.1 Europe Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemostat Powder Sales by Country (2021-2032)
- 5.5.3 Europe Hemostat Powder Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemostat Powder Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemostat Powder Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemostat Powder Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemostat Powder Market Facts & Figures by Country
- 5.7.1 South America Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemostat Powder Sales by Country (2021-2032)
- 5.7.3 South America Hemostat Powder Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemostat Powder Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemostat Powder Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemostat Powder Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemostat Powder Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemostat Powder Sales by Type (2021-2032)
- 6.1.1 Global Hemostat Powder Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hemostat Powder Sales Market Share by Type (2021-2032)
- 6.2 Global Hemostat Powder Revenue by Type (2021-2032)
- 6.2.1 Global Hemostat Powder Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemostat Powder Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemostat Powder Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemostat Powder Sales by Application (2021-2032)
- 7.1.1 Global Hemostat Powder Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hemostat Powder Sales Market Share by Application (2021-2032)
- 7.2 Global Hemostat Powder Revenue by Application (2021-2032)
- 7.2.1 Global Hemostat Powder Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemostat Powder Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemostat Powder Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemostat Powder Value Chain Analysis
- 8.1.1 Hemostat Powder Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemostat Powder Production Mode & Process
- 8.2 Hemostat Powder Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemostat Powder Distributors
- 8.2.3 Hemostat Powder Customers
9 Global Hemostat Powder Analyzing Market Dynamics
- 9.1 Hemostat Powder Industry Trends
- 9.2 Hemostat Powder Industry Drivers
- 9.3 Hemostat Powder Industry Opportunities and Challenges
- 9.4 Hemostat Powder Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst